Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 18,000
- Avg volume
- —
- Day's range
- $0.03 – $0.03
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 780 448 1400
- Website
- https://www.questpharmatech.com
- Address
- 97 Street NW, Suite 4342, Edmonton, Canada
Latest news
No headlines yet.
